

Instance: composition-en-a7a8f3aaed2850db2f524101df25e7ab
InstanceOf: CompositionUvEpi
Title: "Composition for iressa Package Leaflet"
Description:  "Composition for iressa Package Leaflet"
Usage: #inline

* identifier.system = ""

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mock)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - iressa"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet:
1. What IRESSA is and what it is used for
2. What you need to know before you take IRESSA
3. How to take IRESSA
4. Possible side effects
5. How to store IRESSA
6. Contents of the pack and other information</p>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What iressa is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What iressa is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>IRESSA contains the active substance gefitinib which blocks a protein called  epidermal growth factor 
receptor  (EGFR). This protein is involved in the growth and spread of cancer cells.
IRESSA is used to treat adults with non-small cell lung cancer. This cancer is a disease in which 
malignant (cancer) cells form in the tissues of the lung.</p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take iressa"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take iressa"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not take IRESSA</p>
<p>if you are allergic to gefitinib or any of the other ingredients of this medicine (listed in 
section 6,  What IRESSA contains ).</p>
<p>if you are breast-feeding.
Warnings and precautions
Talk to your doctor or pharmacist before taking IRESSA</p>
<p>if you have ever had any other lung problems. Some lung problems may get worse during 
treatment with IRESSA.</p>
<p>if you have ever had problems with your liver.
Children and adolescents
IRESSA is not indicated in children and adolescents under 18 years.
Other medicines and IRESSA
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other 
medicines.
In particular, tell your doctor or pharmacist if you are taking any of the following medicines:</p>
<p>Phenytoin or carbamazepine (for epilepsy).</p>
<p>Rifampicin (for tuberculosis).</p>
<p>Itraconazole (for fungal infections).</p>
<p>Barbiturates (a type of medicine used for sleeping problems).</p>
<p>Herbal remedies containing St John s wort (Hypericum perforatum, used for depression and 
anxiety).</p>
<p>Proton-pump inhibitors, H2-antagonists and antacids (for ulcers, indigestion, heartburn and to 
reduce acids in the stomach).
These medicines may affect the way IRESSA works.</p>
<p>Warfarin (a so-called oral anticoagulant, to prevent blood clots). If you are taking a medicine 
containing this active substance, your doctor may need to do blood tests more often.
If any of the above applies to you, or if you are not sure, check with your doctor or pharmacist before 
taking IRESSA.
Pregnancy, breast-feeding and fertility
Talk to your doctor before taking this medicine if you are pregnant, may become pregnant or are 
breast-feeding.
It is recommended that you avoid becoming pregnant during treatment with IRESSA because IRESSA
could harm your baby.
Do not take IRESSA if you are breast-feeding. This is for the safety of your baby.
Driving and using machines
You may feel weak while taking treatment with Iressa. If this happens, do not drive or use any tools or 
machines.
IRESSA contains lactose
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor 
before taking this medicine.
IRESSA contains sodium
This medicine contains less than 1 mmol (23 mg) of sodium per dose, that is to say it is essentially 
 sodium-free .</p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take iressa"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take iressa"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist 
if you are not sure.</p>
<p>The recommended dose is one 250 mg tablet per day.</p>
<p>Take the tablet at about the same time each day.</p>
<p>You can take the tablet with or without food.</p>
<p>Do not take antacids (to reduce the acid level of your stomach) 2 hours before or 1 hour after 
taking IRESSA.
If you have trouble swallowing the tablet, dissolve it in half a glass of still (non-fizzy) water. Do not 
use any other liquids. Do not crush the tablet. Swirl the water until the tablet has dissolved. This may 
take up to 20 minutes. Drink the liquid straight away. To make sure that you have drunk all of the 
medicine, rinse the glass very well with half a glass of water and drink it.
If you take more IRESSA than you should
If you have taken more tablets than you should, talk to a doctor or pharmacist straight away.
If you forget to take IRESSA
What to do if you forget to take a tablet depends on how long it is until your next dose.</p>
<p>If it is 12 hours or more until your next dose: take the missed tablet as soon as you remember. 
Then take the next dose as usual.</p>
<p>If it is less than 12 hours until your next dose: skip the missed tablet. Then take the next tablet 
at the usual time.
Do not take a double dose (two tablets at the same time) to make up for a forgotten dose.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines this medicine can cause side effects, although not everybody gets them.
Tell your doctor immediately if you notice any of the following side effects - you may need urgent 
medical treatment:</p>
<p>Allergic reaction (common), particularly if symptoms include swollen face, lips, tongue or 
throat, difficulty to swallow, hives, nettle rash and difficulty breathing.</p>
<p>Serious breathlessness, or sudden worsening breathlessness, possibly with a cough or fever. 
This may mean that you have an inflammation of the lungs called  interstitial lung disease . This 
may affect about 1 in 100 patients taking IRESSA and can be life-threatening.</p>
<p>Severe skin reactions (rare) affecting large areas of your body. The signs may include redness, 
pain, ulcers, blisters, and shedding of the skin. The lips, nose, eyes and genitals may also be 
affected.</p>
<p>Dehydration (common) caused by long term or severe diarrhoea, vomiting (being sick), nausea 
(feeling sick) or loss of appetite.</p>
<p>Eye problems (uncommon), such as pain, redness, watery eyes, light sensitivity, changes in 
vision or ingrowing eyelashes. This may mean that you have an ulcer on the surface of the eye 
(cornea).
Tell your doctor as soon as possible if you notice any of the following side effects:
Very common: may affect more than 1 in 10 people</p>
<p>Diarrhoea</p>
<p>Vomiting</p>
<p>Nausea</p>
<p>Skin reactions such as an acne-like rash, which is sometimes itchy with dry and/or cracked
skin</p>
<p>Loss of appetite</p>
<p>Weakness</p>
<p>Red or sore mouth</p>
<p>Increase of a liver enzyme known as alanine aminotransferase in a blood test; if too high, your 
doctor may tell you to stop taking IRESSA
Common: may affect up to 1 in 10 people</p>
<p>Dry mouth</p>
<p>Dry, red or itchy eyes</p>
<p>Red and sore eyelids</p>
<p>Nail problems</p>
<p>Hair loss</p>
<p>Fever</p>
<p>Bleeding (such as nose bleed or blood in your urine)</p>
<p>Protein in your urine (shown in a urine test)</p>
<p>Increase of bilirubin and the other liver enzyme known as aspartate aminotransferase in a <br />
  blood test; if too high, your doctor may tell you to stop taking IRESSA</p>
<p>Increase of creatinine levels in a blood test (related to kidney function)</p>
<p>Cystitis (burning sensations during urination and frequent, urgent need to urinate)
Uncommon: may affect up to 1 in 100 people</p>
<p>Inflammation of the pancreas. The signs include very severe pain in the upper part of the 
stomach area and severe nausea and vomiting.</p>
<p>Inflammation of the liver. Symptoms may include a general feeling of being unwell, with or 
without possible jaundice (yellowing of the skin and eyes). This side effect is uncommon; 
however, some patients have died from this.</p>
<p>Gastrointestinal perforation</p>
<p>Skin reaction on the palms of the hands and soles of the feet including tingling, numbness, 
pain, swelling or reddening (known as palmar-plantar erythrodysaesthesia syndrome or hand 
and foot syndrome).
Rare: may affect up to 1 in 1000 people</p>
<p>Inflammation of the blood vessels in the skin. This may give the appearance of bruising or 
patches of non-blanching rash on the skin.</p>
<p>Haemorrhagic cystitis (burning sensations during urination and frequent, urgent need to 
urinate with blood in the urine).
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side 
effects not listed in this leaflet. You can also report side effects directly via the national reporting 
system listed in Appendix V. By reporting side effects you can help provide more information on the 
safety of this medicine.</p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store iressa"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store iressa"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton, blister and overwrap foil 
after EXP. The expiry date refers to the last day of that month.
Store in the original package in order to protect from moisture.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to 
throw away medicines you no longer use. These measures will help to protect the environment.</p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What IRESSA contains</p>
<p>The active substance is gefitinib. Each tablet contains 250 mg of gefitinib.</p>
<p>The other ingredients (excipients) are lactose monohydrate, microcrystalline cellulose (E460), 
croscarmellose sodium, povidone (K29-32) (E1201), sodium laurilsulfate, magnesium stearate, 
hypromellose (E464), macrogol 300, titanium dioxide (E171), yellow iron oxide (E172) and red 
iron oxide (E172).
What IRESSA looks like and contents of the pack
IRESSA is a round brown tablet marked with  IRESSA 250  on one side and plain on the other.
IRESSA comes in blister packs of 30 tablets. The blister foil may be perforated or non-perforated.
Marketing Authorisation Holder 
AstraZeneca AB
SE-151 S dert lje
Sweden
Manufacturer
AstraZeneca AB
G rtunav gen
SE-152 57 S dert lje
Sweden
AstraZeneca UK Limited
Macclesfield
Cheshire SK10 2NA
United Kingdom
For any information about this medicine, please contact the local representative of the Marketing 
Authorisation Holder:
Belgi /Belgique/Belgien
AstraZeneca S.A./N.V.
Tel: +32 2 370 48 Lietuva
UAB AstraZeneca Lietuva
Tel: +370 5 2660 </p>
<p>.: +359 (2) 44 55 Luxembourg/Luxemburg
AstraZeneca S.A./N.V.
T l/Tel: +32 2 370 48  esk  republika
AstraZeneca Czech Republic s.r.o.
Tel: +420 222 807 Magyarorsz g
AstraZeneca Kft.
Tel.: +36 1 883 6Danmark
AstraZeneca A/S
Tlf: +45 43 66 64 Malta
Associated Drug Co. Ltd
Tel: +356 2277 8Deutschland
AstraZeneca GmbH
Tel: +49 40 809034Nederland
AstraZeneca BV
Tel: +31 79 363 2Eesti
AstraZeneca
Tel: +372 6549 Norge
AstraZeneca AS
Tlf: +47 21 00 64<br />
AstraZeneca A.E.
 : +30 2 106871 sterreich
AstraZeneca  sterreich GmbH
Tel: +43 1 711 31 0
Espa a
AstraZeneca Farmac utica Spain, S.A.
Tel: +34 91 301 91 Polska
AstraZeneca Pharma Poland Sp. z o.o.
Tel.: +48 22 245 73 France
AstraZeneca
T l: +33 1 41 29 40 Portugal
AstraZeneca Produtos Farmac uticos, Lda.
Tel: +351 21 434 61 Hrvatska
AstraZeneca d.o.o.
Tel: +385 1 4628 Rom nia
AstraZeneca Pharma SRL
Tel: +40 21 317 60 Ireland
AstraZeneca Pharmaceuticals (Ireland) DAC
Tel: +353 1609 7Slovenija
AstraZeneca UK Limited
Tel: +386 1 51 35  sland
Vistor hf.
S mi: +354 535 7Slovensk  republika
AstraZeneca AB, o.z.
Tel: +421 2 5737 7Italia
AstraZeneca S.p.A.
Tel: +39 02 00704Suomi/Finland
AstraZeneca Oy
Puh/Tel: +358 10 23  </p>
<p>: +357 22490Sverige
AstraZeneca AB
Tel: +46 8 553 26 Latvija
SIA AstraZeneca Latvija
Tel: +371 67377United Kingdom (Northern Ireland)
AstraZeneca UK Ltd
Tel: +44 1582 836 This leaflet was last revised in 
Other sources of information
Detailed information on this medicine is available on the European Medicines Agency web site: </p>         </div>"""      

